Repetitive transcranial magnetic stimulation combined with olanzapine and amisulpride for treatment-refractory schizophrenia

Table 1 Demographic information

Categories	Control group, n = 54	Research group, n = 60	χ2/t value	P value
Sex			0.069	0.793
Male	32 (59.26)	37 (61.67)
Female	22 (40.74)	23 (38.33)
Age in yr	40.07 ± 7.01	41.28 ± 8.74	0.810	0.420
Course of the disease in yr	19.56 ± 7.55	18.93 ± 5.83	0.501	0.617
Family medical history			0.252	0.616
Yes	6 (11.11)	5 (8.33)
No	48 (88.89)	55 (91.67)
Marital status			0.381	0.537
Married	33 (61.11)	40 (66.67)
Single	21 (38.89)	20 (33.33)
Educational level			1.481	0.224
Below high school	30 (55.56)	40 (66.67)
High school and above	24 (44.44)	20 (33.33)

Data are presented as n (%), unless otherwise indicated.

Table 2 Comparison of the therapeutic effectiveness of the two treatment methods

Indicators	Control group, n = 54	Research group, n = 60	χ2 value	P value
Marked response	19 (35.19)	36 (60.00)	-	-
Response	20 (37.04)	20 (33.33)	-	-
Non-response	15 (27.78)	4 (6.67)	-	-
Overall response	39 (72.22)	56 (93.33)	9.120	0.003

Data are presented as n (%).

Table 3 Comparison of the safety of the two treatment methods

Indicators	Control group, n = 54	Research group, n = 60	χ2 value	P value
Drowsiness	4 (7.41)	1 (1.67)	-	-
Headache	4 (7.41)	1 (1.67)	-	-
Nausea	3 (5.56)	2 (3.33)	-	-
Vomiting	2 (3.70)	1 (1.67)	-	-
Memory impairment	1 (1.85)	0 (0.00)	-	-
Total	14 (25.93)	5 (8.33)	6.333	0.012

Data are presented as n (%).